2010, Number 1
Rev Med Inst Mex Seguro Soc 2010; 48 (1)
Carranza-Lira S, Santos-González J
PDF size: 35.81 Kb.
ABSTRACTBackground: The medical opinion after WHI study has changed. The aim was to know the opinion of Mexican physicians about hormone therapy (HT) after the WHI study.
Methods: there were given 14 questions to 463 physicians to know their opinion on HT according to risks, benefits, doses, indications and contraindications. Descriptive statistics were used for data analysis.
Results: Only 31 % begin HT after 60 years of age and 74 % considered that HT decreased osteoporosis risk; 73 % use progestin in women with uterus. 82 % did not believe that estrogen-progestin HT increased the possibility of endometrial cancer and 51 % believed that breast cancer possibility increased. The main indication for HT prescription was for bone loss diminution (51 %); 88 % considered that low dose HT was as effective as conventional dose.
Conclusions: the use of HT has been modified by Mexican physicians after the WHI study.